192 related articles for article (PubMed ID: 8835750)
1. Effect of terlipressin on in vitro vascular hyporeactivity of portal hypertensive rats.
Heinemann A; Stauber RE
J Hepatol; 1996 Jun; 24(6):739-46. PubMed ID: 8835750
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats.
Heinemann A; Wachter CH; Holzer P; Fickert P; Stauber RE
Br J Pharmacol; 1997 Jul; 121(5):1031-7. PubMed ID: 9222564
[TBL] [Abstract][Full Text] [Related]
3. Renal response to methoxamine in portal hypertensive rats: role of prostaglandins and nitric oxide.
García-Estañ J; Atucha NM; Groszmann RJ
J Hepatol; 1996 Aug; 25(2):206-11. PubMed ID: 8878783
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats.
Heinemann A; Wachter CH; Fickert P; Trauner M; Stauber RE
Hepatology; 1998 Sep; 28(3):646-54. PubMed ID: 9731553
[TBL] [Abstract][Full Text] [Related]
5. The role of inducible nitric oxide synthase in vascular hyporeactivity of endotoxin-treated and portal hypertensive rats.
Heinemann A; Stauber RE
Eur J Pharmacol; 1995 May; 278(1):87-90. PubMed ID: 7545125
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of the novel vasotocin analogue F-180 vs. vasopressin and terlipressin on systemic and splanchnic isolated vessels from portal hypertensive rats.
Ramírez MC; Martínez-Cuesta MA; D'Ocon P; Noguera MA; García-Zaragoza E; Bosch J; Melin P; Esplugues JV
Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3):199-204. PubMed ID: 11521161
[TBL] [Abstract][Full Text] [Related]
7. Chronic inhibition of nitric oxide ameliorates splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.
Huang HC; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Chan CC; Wu SL; Chen CT; Lee SD
Scand J Gastroenterol; 2000 Dec; 35(12):1308-13. PubMed ID: 11199372
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of the increased pressor response to vasopressors in the mesenteric bed of nitric oxide-deficient hypertensive rats.
Ruiz-Marcos FM; Ortíz MC; Fortepiani LA; Nadal FJ; Atucha NM; García-Estañ J
Eur J Pharmacol; 2001 Feb; 412(3):273-9. PubMed ID: 11166291
[TBL] [Abstract][Full Text] [Related]
9. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade.
Sieber CC; Groszmann RJ
Am J Physiol; 1992 Jun; 262(6 Pt 1):G996-1001. PubMed ID: 1616049
[TBL] [Abstract][Full Text] [Related]
10. Vasoconstrictor responsiveness of the rat mesenteric arterial bed in cirrhosis.
Ralevic V; Mathie RT; Moore KP; Burnstock G
Br J Pharmacol; 1996 May; 118(2):435-41. PubMed ID: 8735649
[TBL] [Abstract][Full Text] [Related]
11. Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats.
Moreno L; Martínez-Cuesta MA; Piqué JM; Bosch J; Esplugues JV
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):474-80. PubMed ID: 8897451
[TBL] [Abstract][Full Text] [Related]
12. Mesenteric arterial function in the rat in pregnancy: role of sympathetic and sensory-motor perivascular nerves, endothelium, smooth muscle, nitric oxide and prostaglandins.
Ralevic V; Burnstock G
Br J Pharmacol; 1996 Apr; 117(7):1463-70. PubMed ID: 8730740
[TBL] [Abstract][Full Text] [Related]
13. Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity.
Fernandez M; Lambrecht RW; Bonkovsky HL
J Hepatol; 2001 Jun; 34(6):812-7. PubMed ID: 11451163
[TBL] [Abstract][Full Text] [Related]
14. Mesenteric vasodilator responses in cirrhotic rats: a role for nitric oxide?
Mathie RT; Ralevic V; Moore KP; Burnstock G
Hepatology; 1996 Jan; 23(1):130-6. PubMed ID: 8550032
[TBL] [Abstract][Full Text] [Related]
15. Deletion of inducible nitric oxide synthase decreases mesenteric vascular responsiveness in portal hypertensive mice.
Bexis S; Vandeputte C; McCormick PA; Docherty JR
Eur J Pharmacol; 2004 Sep; 499(3):325-33. PubMed ID: 15381055
[TBL] [Abstract][Full Text] [Related]
16. The effects of perfusion rate and NG-nitro-L-arginine methyl ester on cirazoline- and KCl-induced responses in the perfused mesenteric arterial bed of rats.
Adeagbo AS; Tabrizchi R; Triggle CR
Br J Pharmacol; 1994 Jan; 111(1):13-20. PubMed ID: 7912152
[TBL] [Abstract][Full Text] [Related]
17. Role of cyclic guanosine monophosphate and K+ channels as mediators of the mesenteric vascular hyporesponsiveness in portal hypertensive rats.
Atucha NM; Ortíz MC; Fortepiani LA; Ruiz FM; Martínez C; García-Estañ J
Hepatology; 1998 Apr; 27(4):900-5. PubMed ID: 9580129
[TBL] [Abstract][Full Text] [Related]
18. Mesenteric vascular bed responsiveness in bile duct-ligated rats: roles of opioid and nitric oxide systems.
Namiranian K; Samini M; Mehr SE; Gaskari SA; Rastegar H; Homayoun H; Dehpour AR
Eur J Pharmacol; 2001 Jul; 423(2-3):185-93. PubMed ID: 11448484
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect of a selective vasopressin V1A receptor antagonist SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed.
Heinemann A; Horina G; Stauber RE; Pertl C; Holzer P; Peskar BA
Br J Pharmacol; 1998 Nov; 125(6):1120-7. PubMed ID: 9863637
[TBL] [Abstract][Full Text] [Related]
20. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats.
Lee FY; Albillos A; Colombato LA; Groszmann RJ
Hepatology; 1992 Oct; 16(4):1043-8. PubMed ID: 1398484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
